• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Elara Caring Secures New Strategic Investment from Ares and DaVita

    2/2/26 3:00:00 PM ET
    $ARES
    $DVA
    Investment Managers
    Finance
    Misc Health and Biotechnology Services
    Health Care
    Get the next $ARES alert in real time by email

    Partnership will accelerate Elara's growth and evolution as home health care leader; expand access to high-acuity care for complex diseases through new offerings

    Elara Caring (Elara), a leading national provider of skilled home health, hospice, behavioral health, and personal care services, today announced that it has entered into an agreement for a strategic investment from Ares' Private Equity Group (Ares) and DaVita. The investment is intended to expand access to personalized, clinically advanced care at home for patients with complex and acute needs. Elara will continue to operate as a wholly independent company led by CEO Ananth Mohan and the current management team. Following the closing, the parties will collaborate to help Elara expand access to care through new care models and clinical programs.

    The investment from Ares and DaVita will support Elara's next phase of growth by helping to expand its capacity to deliver specialized, in-home care and launch innovative care models. With Ares' experience growing high-performing healthcare businesses and DaVita's clinical and operational expertise in value-based care, Elara is well positioned to scale programs designed to improve outcomes and address gaps in post-acute care—bringing more consistent support to patients at home.

    "Too often, home-based care is introduced late in the care journey, significantly impacting outcomes and quality of life, especially with our vulnerable populations," said Ananth Mohan, Elara Caring CEO. "This collaboration reflects a shared belief that care should be timelier, more personalized, and meet patients where they are most comfortable—at home. Together with Ares and DaVita, we have an extraordinary opportunity to improve the management of chronic conditions and deliver better results for patients and their loved ones as well as our healthcare system overall. We are thrilled to welcome them as partners."

    "Elara Caring is a leading home care platform defined by a commitment to quality and a patient-first culture," said Kevin Cox, Partner in Ares' Private Equity Group. "We're excited to partner with the Elara team and support their next phase of growth and innovation—expanding access, improving outcomes, and delivering an outstanding experience for patients and team members."

    As a key focus of the investment, DaVita and Elara intend to co‑develop a kidney‑specific home‑based care model. This new model will build upon Elara's existing clinical capabilities and apply DaVita's advanced clinical insights to meet the unique needs of patients with kidney disease, seeking to reduce preventable hospitalizations, and helping to lower the total cost of care. The program will seek to offer patients a new pathway to receive high‑quality, tailored support in the comfort of their own homes, and empower providers with a vital resource to ensure high-touch, continuity of care.

    "Through our integrated care programs, we saw meaningful differences in patient outcomes that were closely tied to the quality of home‑based support they received," said Steve Phillips, Chief Strategy Officer of DaVita. "Strengthening access to Elara Caring's exceptional services will help more patients maintain stability at home, avoid unnecessary hospitalizations, and ultimately experience a better quality of life."

    The closing of the transaction is subject to customary closing conditions, including receipt of regulatory approvals, and is expected to occur later in 2026. The terms of the transaction were not disclosed.

    Harris Williams and Evercore are serving as financial advisors, Skadden, Arps, Slate, Meagher & Flom LLP is serving as legal counsel and Debevoise & Plimpton LLP is serving as financing counsel for Elara Caring. Guggenheim Securities, LLC is serving as financial advisor and Ropes & Gray LLP and McDermott Will & Schulte are serving as legal advisors to Ares and DaVita.

    About Elara Caring

    Elara Caring is among the nation's leading providers of high-quality, value-based home care, offering Skilled Home Health, Hospice, Personal Care Services, Behavioral Health, and Palliative Care. With a footprint in 18 states, it serves more than 60,000 patients and clients daily across 200 locations. At Elara, care is delivered by skilled, compassionate professionals dedicated to supporting patients with expertise and empathy. Through care innovation and a commitment to excellence, Elara ensures patients receive the right care when and where they need it most.

    About Ares Management

    Ares Management Corporation (NYSE:ARES) is a leading global alternative investment manager offering clients complementary primary and secondary investment solutions across the credit, real estate, private equity and infrastructure asset classes. We seek to advance our stakeholders' long-term goals by providing flexible capital that supports businesses and creates value for our investors and within our communities. By collaborating across our investment groups, we aim to generate consistent and attractive investment returns throughout market cycles. As of September 30, 2025, Ares Management Corporation's global platform had over $595 billion of assets under management, with operations across North America, South America, Europe, Asia Pacific and the Middle East. For more information, please visit www.aresmgmt.com.

    About DaVita Inc.

    DaVita (NYSE:DVA) is a health care provider focused on transforming care delivery to improve quality of life for patients globally. As a comprehensive kidney care provider, DaVita has been a leader in clinical quality and innovation for 25 years. DaVita cares for patients at every stage and setting along their kidney health journey—from slowing the progression of kidney disease to helping to support transplantation, from acute hospital care to dialysis at home. As of September 30, 2025, DaVita served approximately 293,200 patients at 3,247 outpatient dialysis centers, of which 2,662 centers were located in the United States and 585 centers were located in 14 other countries worldwide. DaVita has reduced hospitalizations, improved mortality, helped improve health access and worked collaboratively to propel the kidney care community to adopt a higher quality standard of care for all patients, everywhere. To learn more, visit DaVita.com/About.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20260202982929/en/

    Elara Caring Media Contact:

    Sharon Horowitz

    shorowitz@resilere.com

    631-807-8149



    Ares Management Contact:

    media@aresmgmt.com



    DaVita Media Contact:

    newsroom@davita.com

    Get the next $ARES alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ARES
    $DVA

    CompanyDatePrice TargetRatingAnalyst
    DaVita Inc.
    $DVA
    5/6/2026$220.00Hold → Buy
    Deutsche Bank
    Ares Management Corporation
    $ARES
    2/9/2026$157.00Mkt Perform → Strong Buy
    Raymond James
    Ares Management Corporation
    $ARES
    2/6/2026Hold → Buy
    Deutsche Bank
    Ares Management Corporation
    $ARES
    12/11/2025$201.00Neutral
    UBS
    Ares Management Corporation
    $ARES
    10/14/2025$180.00Perform → Outperform
    Oppenheimer
    Ares Management Corporation
    $ARES
    10/3/2025$156.00Market Perform
    BMO Capital Markets
    Ares Management Corporation
    $ARES
    7/28/2025Mkt Perform
    Raymond James
    Ares Management Corporation
    $ARES
    5/15/2025Outperform → Perform
    Oppenheimer
    More analyst ratings

    $ARES
    $DVA
    SEC Filings

    View All

    SEC Form 11-K filed by DaVita Inc.

    11-K - DAVITA INC. (0000927066) (Filer)

    6/17/26 5:22:30 PM ET
    $DVA
    Misc Health and Biotechnology Services
    Health Care

    Ares Management Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - Ares Management Corp (0001176948) (Filer)

    6/11/26 5:24:48 PM ET
    $ARES
    Investment Managers
    Finance

    DaVita Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    8-K - DAVITA INC. (0000927066) (Filer)

    6/8/26 4:33:52 PM ET
    $DVA
    Misc Health and Biotechnology Services
    Health Care

    $ARES
    $DVA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Legal & Pub. Affairs Off Waters Kathleen Alyce sold $3,210,377 worth of shares (15,405 units at $208.40) as part of a pre-agreed trading plan, decreasing direct ownership by 12% to 109,194 units (SEC Form 4)

    4 - DAVITA INC. (0000927066) (Issuer)

    6/17/26 6:10:24 PM ET
    $DVA
    Misc Health and Biotechnology Services
    Health Care

    Chief Executive Officer Rodriguez Javier sold $14,532,108 worth of shares (69,407 units at $209.38), decreasing direct ownership by 8% to 840,408 units (SEC Form 4)

    4 - DAVITA INC. (0000927066) (Issuer)

    6/17/26 6:09:34 PM ET
    $DVA
    Misc Health and Biotechnology Services
    Health Care

    Co-President Jacobson Blair gifted 8,000 shares, decreasing direct ownership by 0.72% to 1,103,221 units (SEC Form 4)

    4 - Ares Management Corp (0001176948) (Issuer)

    6/4/26 8:53:50 PM ET
    $ARES
    Investment Managers
    Finance

    $ARES
    $DVA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    DaVita upgraded by Deutsche Bank with a new price target

    Deutsche Bank upgraded DaVita from Hold to Buy and set a new price target of $220.00

    5/6/26 7:31:43 AM ET
    $DVA
    Misc Health and Biotechnology Services
    Health Care

    Ares Management upgraded by Raymond James with a new price target

    Raymond James upgraded Ares Management from Mkt Perform to Strong Buy and set a new price target of $157.00

    2/9/26 8:10:55 AM ET
    $ARES
    Investment Managers
    Finance

    Ares Management upgraded by Deutsche Bank

    Deutsche Bank upgraded Ares Management from Hold to Buy

    2/6/26 8:00:49 AM ET
    $ARES
    Investment Managers
    Finance

    $ARES
    $DVA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Olian Judy D. bought $59,726 worth of shares (480 units at $124.43), increasing direct ownership by 2% to 29,734 units (SEC Form 4)

    4 - Ares Management Corp (0001176948) (Issuer)

    2/24/26 6:50:31 PM ET
    $ARES
    Investment Managers
    Finance

    Director Bhutani Ashish bought $1,266,100 worth of shares (10,000 units at $126.61), increasing direct ownership by 42% to 34,071 units (SEC Form 4)

    4 - Ares Management Corp (0001176948) (Issuer)

    2/10/26 5:09:08 PM ET
    $ARES
    Investment Managers
    Finance

    Director Bhutani Ashish bought $1,413,300 worth of shares (10,000 units at $141.33), increasing direct ownership by 77% to 22,905 units (SEC Form 4)

    4 - Ares Management Corp (0001176948) (Issuer)

    3/13/25 8:14:14 PM ET
    $ARES
    Investment Managers
    Finance

    $ARES
    $DVA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Ares Appoints Brent Canada as Head of Infrastructure Debt

    Lorenzo Ceretti Joins Roopa Murthy as Co-Head of EMEA Infrastructure Debt Ares Management Corporation (NYSE:ARES) ("Ares"), a leading global alternative investment manager, announced today that Brent Canada has been appointed Head of Ares Infrastructure Debt. Mr. Canada joined Ares as a Partner in 2022 from Deutsche Bank, where he was a Managing Director and responsible for infrastructure financing coverage in the Americas. After leading the Infrastructure Debt team at Ares since its acquisition in 2022, Patrick Trears has decided to transition to Senior Advisor from his role as Head of Ares Infrastructure Debt. In addition, underscoring the expanding opportunity in the global infrastru

    6/18/26 6:30:00 AM ET
    $ARES
    Investment Managers
    Finance

    Development of Parkside Commerce Center, a New Premier Class-A Industrial Facility, Launches in RTP

    DURHAM, N.C., June 15, 2026 /PRNewswire/ -- Foundry Commercial, on behalf of Hines and an Ares Real Estate fund ("Ares"), has announced the start of construction at Parkside Commerce Center, a new four-building, 809,141-square-foot Class-A industrial development located on Silicon Drive in Durham, North Carolina, directly adjacent to Research Triangle Park (RTP). The project represents one of the premier new industrial developments in the Raleigh-Durham ("RDU") market and is designed to serve a broad range of occupiers, including companies supporting the region's nationally recognized advanced manufacturing and biomanufacturing

    6/15/26 11:23:00 AM ET
    $ARES
    Investment Managers
    Finance

    ARES CAPITAL CORPORATION ANNOUNCES INAUGURAL $1 BILLION COMMERCIAL PAPER PROGRAM

    NEW YORK, June 8, 2026 /PRNewswire/ -- Ares Capital Corporation ("Ares Capital" or the "Company") (NASDAQ:ARCC) announced today the establishment of its inaugural commercial paper program. The program allows the Company to issue up to a maximum aggregate amount outstanding at any time of $1 billion of short-term, unsecured commercial paper notes. The notes will be sold under customary terms in the United States commercial paper note market and will rank pari passu with the Company's other senior unsecured indebtedness. The Company expects to realize cost benefits in the commercial paper market relative to other funding sources, and it expects to use available borrowing capacity from its $5.5

    6/8/26 7:30:00 AM ET
    $ARCC
    $ARES
    Finance: Consumer Services
    Finance
    Investment Managers

    $ARES
    $DVA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Ares Management Corporation

    SC 13G/A - Ares Management Corp (0001176948) (Subject)

    11/14/24 4:06:22 PM ET
    $ARES
    Investment Managers
    Finance

    Amendment: SEC Form SC 13G/A filed by Ares Management Corporation

    SC 13G/A - Ares Management Corp (0001176948) (Subject)

    11/14/24 4:05:07 PM ET
    $ARES
    Investment Managers
    Finance

    SEC Form SC 13G/A filed by DaVita Inc. (Amendment)

    SC 13G/A - DAVITA INC. (0000927066) (Subject)

    2/13/24 5:02:42 PM ET
    $DVA
    Misc Health and Biotechnology Services
    Health Care

    $ARES
    $DVA
    Leadership Updates

    Live Leadership Updates

    View All

    Ares Appoints Brent Canada as Head of Infrastructure Debt

    Lorenzo Ceretti Joins Roopa Murthy as Co-Head of EMEA Infrastructure Debt Ares Management Corporation (NYSE:ARES) ("Ares"), a leading global alternative investment manager, announced today that Brent Canada has been appointed Head of Ares Infrastructure Debt. Mr. Canada joined Ares as a Partner in 2022 from Deutsche Bank, where he was a Managing Director and responsible for infrastructure financing coverage in the Americas. After leading the Infrastructure Debt team at Ares since its acquisition in 2022, Patrick Trears has decided to transition to Senior Advisor from his role as Head of Ares Infrastructure Debt. In addition, underscoring the expanding opportunity in the global infrastru

    6/18/26 6:30:00 AM ET
    $ARES
    Investment Managers
    Finance

    Ares Appoints Peter Ogilvie as Chief Operating Officer and Head of Strategy

    Ares Management Corporation (NYSE:ARES) ("Ares"), a leading global alternative investment manager, announced today that Peter Ogilvie has been appointed as Chief Operating Officer and Head of Strategy, where he will support the leadership team in executing the firm's strategic growth initiatives while scaling some of Ares' key global operating capabilities. Mr. Ogilvie currently serves as a Partner and Head of the Ares Corporate Strategy Group, where he has played a central role in shaping the firm's long‑term strategic direction. He joined Ares in 2007 on the direct lending team and has been instrumental in the acquisitions of Allied Capital, American Capital, Black Creek Group, Landmark

    4/29/26 6:30:00 AM ET
    $ARES
    Investment Managers
    Finance

    E.G. Morse to Join Ares as Head of Asia Credit and Dinesh Goel and Gabriel Fong Appointed as Co-Heads of the Asia Special Situations Strategy

    Edwin Wong Retiring as Head of Asia Credit Ares Management Corporation (NYSE:ARES) ("Ares"), a leading global alternative investment manager, announced today that E.G. Morse will join Ares as Partner and Head of Asia Credit. Mr. Morse most recently served as Co-Head of China and Head of China Global Markets for Goldman Sachs Group, Inc. ("Goldman Sachs"). Ares is also pleased to announce the appointment of Dinesh Goel and Gabriel Fong as Co-Heads of the Asia Special Situations strategy, effective immediately. After a distinguished tenure, Edwin Wong has decided to retire from his role as Head of Asia Credit, effective June 30, 2026. Mr. Morse will be based in Hong Kong. He will be respo

    4/8/26 9:00:00 PM ET
    $ARES
    Investment Managers
    Finance

    $ARES
    $DVA
    Financials

    Live finance-specific insights

    View All

    DaVita Inc. 1st Quarter 2026 Results

    DENVER, May 5, 2026 /PRNewswire/ -- DaVita Inc. (NYSE:DVA) announced financial and operating results for the quarter ended March 31, 2026."DaVita's foundation is clinical excellence, driven by operating rigor that produces durable results," said Javier Rodriguez, CEO of DaVita Inc. "We have consistently delivered exceptional clinical outcomes and strong financial performance, and this quarter is no exception."Financial and operating highlights for the quarter and year ended March 31, 2026:Consolidated revenues were $3.416 billion.Operating income was $482 million.Diluted earnings per share from continuing operations was $2.87.Operating cash flow was $321 million and free cash flow was $140 m

    5/5/26 4:05:00 PM ET
    $DVA
    Misc Health and Biotechnology Services
    Health Care

    Ares Management Corporation Reports First Quarter 2026 Results

    Ares Management Corporation (NYSE:ARES) today reported its financial results for its first quarter ended March 31, 2026. GAAP net income attributable to Ares Management Corporation was $142.6 million for the quarter ended March 31, 2026. On a basic and diluted basis, net income attributable to Ares Management Corporation per share of Class A and non-voting common stock was $0.46 for the quarter ended March 31, 2026. After-tax realized income was $452.4 million for the quarter ended March 31, 2026. After-tax realized income per share of Class A common stock was $1.24 for the quarter ended March 31, 2026. Fee related earnings were $464.4 million for the quarter ended March 31, 2026. "We

    5/1/26 6:00:00 AM ET
    $ARES
    Investment Managers
    Finance

    Ares Capital Corporation Announces March 31, 2026 Financial Results and Declares Second Quarter 2026 Dividend of $0.48 Per Share

    Dividend Declarations Ares Capital Corporation ("Ares Capital") (NASDAQ:ARCC) announced that its Board of Directors has declared a second quarter 2026 dividend of $0.48 per share. The second quarter 2026 dividend is payable on June 30, 2026 to stockholders of record as of June 15, 2026. MARCH 31, 2026 FINANCIAL RESULTS Ares Capital also announced financial results for its first quarter ended March 31, 2026. OPERATING RESULTS     Q1-26(3)   Q1-25(3) (dollar amounts in millions, except per share data)   Total Amount   Per Share   Total Amount   Per Share GAAP net income per share(1)

    4/28/26 7:00:00 AM ET
    $ARCC
    $ARES
    Finance: Consumer Services
    Finance
    Investment Managers